Literature DB >> 26619120

RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure.

Chen Gao, Shuxun Ren, Jae-Hyung Lee, Jinsong Qiu, Douglas J Chapski, Christoph D Rau, Yu Zhou, Maha Abdellatif, Astushi Nakano, Thomas M Vondriska, Xinshu Xiao, Xiang-Dong Fu, Jau-Nian Chen, Yibin Wang.   

Abstract

RNA splicing is a major contributor to total transcriptome complexity; however, the functional role and regulation of splicing in heart failure remain poorly understood. Here, we used a total transcriptome profiling and bioinformatic analysis approach and identified a muscle-specific isoform of an RNA splicing regulator, RBFox1 (also known as A2BP1), as a prominent regulator of alternative RNA splicing during heart failure. Evaluation of developing murine and zebrafish hearts revealed that RBFox1 is induced during postnatal cardiac maturation. However, we found that RBFox1 is markedly diminished in failing human and mouse hearts. In a mouse model, RBFox1 deficiency in the heart promoted pressure overload-induced heart failure. We determined that RBFox1 is a potent regulator of RNA splicing and is required for a conserved splicing process of transcription factor MEF2 family members that yields different MEF2 isoforms with differential effects on cardiac hypertrophic gene expression. Finally, induction of RBFox1 expression in murine pressure overload models substantially attenuated cardiac hypertrophy and pathological manifestations. Together, this study identifies regulation of RNA splicing by RBFox1 as an important player in transcriptome reprogramming during heart failure that influence pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26619120      PMCID: PMC4701548          DOI: 10.1172/JCI84015

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

Review 1.  Alternative splicing: global insights.

Authors:  Martina Hallegger; Miriam Llorian; Christopher W J Smith
Journal:  FEBS J       Date:  2010-01-15       Impact factor: 5.542

2.  A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome.

Authors:  Marc Sultan; Marcel H Schulz; Hugues Richard; Alon Magen; Andreas Klingenhoff; Matthias Scherf; Martin Seifert; Tatjana Borodina; Aleksey Soldatov; Dmitri Parkhomchuk; Dominic Schmidt; Sean O'Keeffe; Stefan Haas; Martin Vingron; Hans Lehrach; Marie-Laure Yaspo
Journal:  Science       Date:  2008-07-03       Impact factor: 47.728

3.  The RNA-binding protein Rbfox1 regulates splicing required for skeletal muscle structure and function.

Authors:  Simona Pedrotti; Jimena Giudice; Adan Dagnino-Acosta; Mark Knoblauch; Ravi K Singh; Amy Hanna; Qianxing Mo; John Hicks; Susan Hamilton; Thomas A Cooper
Journal:  Hum Mol Genet       Date:  2015-01-09       Impact factor: 6.150

4.  RNA-binding protein RBM24 is required for sarcomere assembly and heart contractility.

Authors:  Kar Lai Poon; Kar Tong Tan; Yang Ye Wei; Chee Peng Ng; Alan Colman; Vladimir Korzh; Xiu Qin Xu
Journal:  Cardiovasc Res       Date:  2012-02-15       Impact factor: 10.787

5.  RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.

Authors:  Wei Guo; Sebastian Schafer; Marion L Greaser; Michael H Radke; Martin Liss; Thirupugal Govindarajan; Henrike Maatz; Herbert Schulz; Shijun Li; Amanda M Parrish; Vita Dauksaite; Padmanabhan Vakeel; Sabine Klaassen; Brenda Gerull; Ludwig Thierfelder; Vera Regitz-Zagrosek; Timothy A Hacker; Kurt W Saupe; G William Dec; Patrick T Ellinor; Calum A MacRae; Bastian Spallek; Robert Fischer; Andreas Perrot; Cemil Özcelik; Kathrin Saar; Norbert Hubner; Michael Gotthardt
Journal:  Nat Med       Date:  2012-05       Impact factor: 53.440

6.  A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

Authors:  Auinash Kalsotra; Xinshu Xiao; Amanda J Ward; John C Castle; Jason M Johnson; Christopher B Burge; Thomas A Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

7.  Splicing factor and exon profiling across human tissues.

Authors:  Pierre de la Grange; Lise Gratadou; Marc Delord; Martin Dutertre; Didier Auboeuf
Journal:  Nucleic Acids Res       Date:  2010-01-27       Impact factor: 16.971

Review 8.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

9.  Rbfox proteins regulate tissue-specific alternative splicing of Mef2D required for muscle differentiation.

Authors:  Valeria Runfola; Soji Sebastian; F Jeffrey Dilworth; Davide Gabellini
Journal:  J Cell Sci       Date:  2015-01-20       Impact factor: 5.285

10.  Pathophysiological defects and transcriptional profiling in the RBM20-/- rat model.

Authors:  Wei Guo; Jonathan M Pleitner; Kurt W Saupe; Marion L Greaser
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

View more
  64 in total

1.  Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure.

Authors:  Haipeng Sun; Kristine C Olson; Chen Gao; Domenick A Prosdocimo; Meiyi Zhou; Zhihua Wang; Darwin Jeyaraj; Ji-Youn Youn; Shuxun Ren; Yunxia Liu; Christoph D Rau; Svati Shah; Olga Ilkayeva; Wen-Jun Gui; Noelle S William; R Max Wynn; Christopher B Newgard; Hua Cai; Xinshu Xiao; David T Chuang; Paul Christian Schulze; Christopher Lynch; Mukesh K Jain; Yibin Wang
Journal:  Circulation       Date:  2016-04-08       Impact factor: 29.690

2.  Dose-dependent action of the RNA binding protein FOX-1 to relay X-chromosome number and determine C. elegans sex.

Authors:  Behnom Farboud; Catherine S Novak; Monique Nicoll; Alyssa Quiogue; Barbara J Meyer
Journal:  Elife       Date:  2020-12-29       Impact factor: 8.140

Review 3.  Developmental regulation of RNA processing by Rbfox proteins.

Authors:  John G Conboy
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-10-17       Impact factor: 9.957

Review 4.  Cardiomyocyte Maturation: New Phase in Development.

Authors:  Yuxuan Guo; William T Pu
Journal:  Circ Res       Date:  2020-04-09       Impact factor: 17.367

Review 5.  Alternative splicing as a regulator of development and tissue identity.

Authors:  Francisco E Baralle; Jimena Giudice
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

6.  Exclusion of alternative exon 33 of CaV1.2 calcium channels in heart is proarrhythmogenic.

Authors:  Guang Li; Juejin Wang; Ping Liao; Peter Bartels; Hengyu Zhang; Dejie Yu; Mui Cheng Liang; Kian Keong Poh; Chye Yun Yu; Fengli Jiang; Tan Fong Yong; Yuk Peng Wong; Zhenyu Hu; Hua Huang; Guangqin Zhang; Mary Joyce Galupo; Jin-Song Bian; Sathivel Ponniah; Scott Lee Trasti; Kelvin See; Roger Foo; Uta C Hoppe; Stefan Herzig; Tuck Wah Soong
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-10       Impact factor: 11.205

7.  miR-212/132 Cluster Modulation Prevents Doxorubicin-Mediated Atrophy and Cardiotoxicity.

Authors:  Shashi Kumar Gupta; Ankita Garg; Petros Avramopoulos; Stefan Engelhardt; Katrin Streckfuss-Bömeke; Sandor Batkai; Thomas Thum
Journal:  Mol Ther       Date:  2018-11-13       Impact factor: 11.454

8.  Keto acid metabolites of branched-chain amino acids inhibit oxidative stress-induced necrosis and attenuate myocardial ischemia-reperfusion injury.

Authors:  Weibing Dong; Meiyi Zhou; Mei Dong; Bangfen Pan; Yunxia Liu; Jing Shao; Xiaoping Gu; Ying Huang; Guangping Li; Yibin Wang; Haipeng Sun
Journal:  J Mol Cell Cardiol       Date:  2016-11-08       Impact factor: 5.000

9.  Developmentally regulated alternative splicing is perturbed in type 1 diabetic skeletal muscle.

Authors:  Curtis A Nutter; Elizabeth Jaworski; Sunil K Verma; Yareli Perez-Carrasco; Muge N Kuyumcu-Martinez
Journal:  Muscle Nerve       Date:  2017-04-17       Impact factor: 3.217

10.  MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity.

Authors:  Eros Di Giorgio; Liqing Wang; Yan Xiong; Tatiana Akimova; Lanette M Christensen; Rongxiang Han; Arabinda Samanta; Matteo Trevisanut; Tricia R Bhatti; Ulf H Beier; Wayne W Hancock
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.